Silver Diamine Fluoride for Molar Hypomineralization
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether silver diamine fluoride (SDF) can reduce pain during dental work for individuals with molar-incisor hypoplasia (MIH), a condition that weakens teeth. Researchers aim to determine if applying 38% SDF before dental procedures enhances the effectiveness of local anesthesia and reduces pain during treatment. Participants will receive either SDF or a placebo (a harmless liquid) on their affected molars two weeks before dental care. Those with a permanent molar requiring cavity treatment and who can manage basic behavior guidance may be suitable candidates. As an unphased trial, this study provides a unique opportunity to enhance understanding of how SDF can improve dental care for those with MIH.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that silver diamine fluoride (SDF) is generally safe for dental use. Dentists often use it to stop tooth decay, and it has FDA approval for treating sensitive teeth. Studies have found that SDF can make teeth harder and denser, which is beneficial. However, it might cause minor side effects such as irritation to the skin, eyes, or respiratory system, which are usually mild. Overall, SDF is considered a well-tolerated option in dental care.12345
Why are researchers excited about this trial?
Researchers are excited about Silver Diamine Fluoride (SDF) because it offers a unique approach to treating molar hypomineralization. Unlike traditional treatments that often involve invasive procedures like fillings or crowns, SDF is simply painted onto the tooth. It works by using a high concentration of fluoride, which helps strengthen the tooth enamel and prevent further decay. This non-invasive method not only simplifies the treatment process but also reduces discomfort for patients, making it an appealing option for managing this dental condition.
What evidence suggests that this trial's treatments could be effective for molar hypomineralization?
In this trial, participants will receive either silver diamine fluoride (SDF) at 38% or a placebo treatment. Research has shown that SDF is effective for dental treatments. Studies have found that SDF reduces the likelihood of tooth decay by decreasing the permeability of dental tissues. This treatment can halt the progression of cavities. In past studies, SDF successfully prevented further tooth decay and received positive feedback from both patients and parents, particularly for treating molars with conditions like molar-incisor hypoplasia (MIH). This makes it a promising option for managing dental pain and enhancing the effectiveness of local anesthesia during dental procedures.25678
Who Is on the Research Team?
James Boynton, DDS
Principal Investigator
University of Michigan
Are You a Good Fit for This Trial?
This trial is for children with a condition called molar-incisor hypomineralization who need dental work done on their molars. They should be generally healthy or have mild systemic disease, able to understand English, and manageable with basic non-drug guidance or laughing gas during dental procedures.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-treatment
Application of 38% SDF or placebo to hypomineralized permanent molar
Treatment
Restorative care of the tooth following pre-treatment
Follow-up
Participants are monitored for local anesthesia efficacy and tooth sensitivity
What Are the Treatments Tested in This Trial?
Interventions
- Placebo
- SDF
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan
Lead Sponsor